Filtros de búsqueda

Lista de obras de John Buse

1,5-anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes

artículo científico publicado en 2006

2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

scientific article published on 19 December 2019

2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

artículo científico publicado en 2020

A Mixed-Methods, Randomized Clinical Trial to Examine Feasibility of a Mindfulness-Based Stress Management and Diabetes Risk Reduction Intervention for African Americans with Prediabetes

artículo científico publicado en 2019

A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia

artículo científico publicado en 2005

A comparison of lipid and lipoprotein measurements in the fasting and nonfasting states in patients with type 2 diabetes

artículo científico publicado en 2007

A dead heat: target normal glucose levels in the intensive care unit--but with caution

artículo científico publicado en 2008

A genome-wide study of lipid response to fenofibrate in Caucasians: a combined analysis of the GOLDN and ACCORD studies

artículo científico publicado en 2016

A retrospective cohort study of diabetes mellitus and antipsychotic treatment in the United States

scientific article published on 01 February 2003

Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial: Design and Methods

article

Addition of exenatide BID to insulin glargine: a post-hoc analysis of the effect on glycemia and weight across a range of insulin titration

artículo científico publicado en 2014

Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis

artículo científico publicado en 2010

Ambient PM2.5 exposure up-regulates the expression of costimulatory receptors on circulating monocytes in diabetic individuals

artículo científico publicado en 2010

Amylase, Lipase, and Acute Pancreatitis in People With Type 2 Diabetes Treated With Liraglutide: Results From the LEADER Randomized Trial.

artículo científico publicado en 2017

Are prescribing patterns of antidiabetic medications influenced by fears of litigation?

artículo científico publicado en 2008

Are “Hemochromatosis gene” mutations a risk factor for type 2 diabetes?

article

Association Between Sitagliptin Use and Heart Failure Hospitalization and Related Outcomes in Type 2 Diabetes Mellitus: Secondary Analysis of a Randomized Clinical Trial

artículo científico

Association of Fenofibrate Therapy With Long-term Cardiovascular Risk in Statin-Treated Patients With Type 2 Diabetes

artículo científico

Association of cardiac and vascular changes with ambient PM2.5 in diabetic individuals

artículo científico publicado en 2010

Associations between arsenic species in exfoliated urothelial cells and prevalence of diabetes among residents of Chihuahua, Mexico

artículo científico publicado en 2014

Autoimmune endocrine disease

artículo científico publicado en 1985

Baseline characteristics of patients enrolled in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL).

artículo científico publicado en 2017

Baseline factors associated with glycemic control and weight loss when exenatide twice daily is added to optimized insulin glargine in patients with type 2 diabetes

artículo científico publicado en 2012

Baseline predictors of A1C reduction in adults using sensor-augmented pump therapy or multiple daily injection therapy: the STAR 3 experience

artículo científico publicado en 2011

Benefits of combination of insulin degludec and liraglutide are independent of baseline glycated haemoglobin level and duration of type 2 diabetes

artículo científico publicado en 2015

Beyond metformin: safety considerations in the decision-making process for selecting a second medication for type 2 diabetes management: reflections from a diabetes care editors' expert forum

artículo científico publicado en 2014

Bio-inspired synthetic nanovesicles for glucose-responsive release of insulin

artículo científico publicado en 2014

COVID-19 in People With Diabetes: Urgently Needed Lessons From Early Reports

artículo científico publicado en 2020

CTSA Consortium Consensus Scientific Review Committee (SRC) Working Group Report on the SRC Processes

artículo científico publicado en 2015

Can We RISE to the Challenge of Youth-Onset Type 2 Diabetes?

artículo científico publicado en 2018

Can we become victims of our own success?

artículo científico publicado en 2009

Cancer incidence among those initiating insulin therapy with glargine versus human NPH insulin

scientific article published on 22 July 2013

Cardiometabolic risk assessments by body mass index z-score or waist-to-height ratio in a multiethnic sample of sixth-graders

artículo científico publicado en 2014

Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From a Diabetes Care Editors' Expert Forum

artículo científico publicado en 2018

Cardiovascular Risk Reduction With Liraglutide: An Exploratory Mediation Analysis of the LEADER Trial

scientific article published on 04 May 2020

Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis

artículo científico publicado en 2017

Cardiovascular safety of liraglutide assessed in a patient-level pooled analysis of phase 2—3 liraglutide clinical development studies

article

Cardiovascular safety of the glucagon-like peptide-1 receptor agonist taspoglutide in people with type 2 diabetes: an individual participant data meta-analysis of randomized controlled trials.

artículo científico publicado en 2015

Causes of Death in a Contemporary Cohort of Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: Insights From the TECOS Trial.

artículo científico publicado en 2017

Changes in Serum Calcitonin Concentrations, Incidence of Medullary Thyroid Carcinoma, and Impact of Routine Calcitonin Concentration Monitoring in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL)

scientific article published on 22 April 2019

Characterizing the weight-glycemia phenotypes of type 1 diabetes in youth and young adulthood

artículo científico publicado en 2020

Charge-switchable polymeric complex for glucose-responsive insulin delivery in mice and pigs

scientific article published on 10 July 2019

Chronic Exposure to Arsenic and Markers of Cardiometabolic Risk: A Cross-Sectional Study in Chihuahua, Mexico

artículo científico publicado en 2015

Class I, II and III major histocompatibility complex gene polymorphisms in BB rats

article

Clinical care guidelines: too much of a good thing?

artículo científico publicado en 2010

Clinical experience with continuous glucose monitoring in adults

scientific article published on June 2009

Common and rare genetic markers of lipid variation in subjects with type 2 diabetes from the ACCORD clinical trial

scientific article published in 2017

Comparative Effect of Initiating Metformin Versus Sulfonylureas on Breast Cancer Risk in Older Women

artículo científico publicado en 2017

Comparative effectiveness of canagliflozin, SGLT2 inhibitors and non-SGLT2 inhibitors on the risk of hospitalization for heart failure and amputation in patients with type 2 diabetes mellitus: A real-world meta-analysis of 4 observational databases (

artículo científico publicado en 2018

Comparative safety of pioglitazone versus clinically meaningful treatment alternatives concerning the risk of bladder cancer in older US adults with type 2 diabetes

artículo científico publicado en 2017

Concomitant Oral Antihyperglycemic Agent Use and Associated Treatment Outcomes After Initiation of Insulin Therapy

article

Confirming the Bidirectional Nature of the Association Between Severe Hypoglycemic and Cardiovascular Events in Type 2 Diabetes: Insights From EXSCEL

artículo científico publicado en 2019

Contribution of liraglutide in the fixed-ratio combination of insulin degludec and liraglutide (IDegLira).

artículo científico publicado en 2014

Cystic fibrosis transmembrane regulator mRNA expression relative to ion-nutrient transport in spontaneously differentiating human intestinal CaCo-2 epithelial cells.

artículo científico publicado en 1991

DURATION-1: exenatide once weekly produces sustained glycemic control and weight loss over 52 weeks

artículo científico publicado en 2010

DURAbility of basal versus lispro mix 75/25 insulin efficacy (DURABLE) trial 24-week results: safety and efficacy of insulin lispro mix 75/25 versus insulin glargine added to oral antihyperglycemic drugs in patients with type 2 diabetes

artículo científico publicado en 2009

Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2).

artículo científico publicado en 2017

Decreased Antihyperglycemic Drug Use Driven by High Out-of-Pocket Costs Despite Medicare Coverage Gap Closure

artículo científico publicado en 2020

Design of DEVOTE (Trial Comparing Cardiovascular Safety of Insulin Degludec vs Insulin Glargine in Patients With Type 2 Diabetes at High Risk of Cardiovascular Events) - DEVOTE 1.

artículo científico publicado en 2016

Design of the Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) Trial

artículo científico publicado en 2008

Design of the liraglutide effect and action in diabetes: evaluation of cardiovascular outcome results (LEADER) trial.

artículo científico publicado en 2013

Development and validation of the Diabetes Numeracy Test (DNT)

artículo científico publicado en 2008

Diabetes and periodontal therapy

artículo científico publicado en 2014

Diabetes educators' knowledge, opinions and behaviors regarding periodontal disease and diabetes

artículo científico publicado en 2012

Diabetes screening with hemoglobin A(1c) versus fasting plasma glucose in a multiethnic middle-school cohort

artículo científico publicado en 2012

Differential Use of Screening Mammography in Older Women Initiating Metformin versus Sulfonylurea.

artículo científico publicado en 2017

Dipeptidyl Peptidase 4 Inhibitors and Risk of Inflammatory Bowel Disease: Real-world Evidence in U.S. Adults

scientific article published on 30 August 2019

Dipeptidyl-peptidase-4 inhibitors and pancreatic cancer: a cohort study

artículo científico publicado en 2014

Disordered cellular immunity in type 1 diabetes of man and the BB rat ⬇️

artículo científico publicado el 1 de enero de 1982

Drug Delivery: Microneedles Integrated with Pancreatic Cells and Synthetic Glucose-Signal Amplifiers for Smart Insulin Delivery (Adv. Mater. 16/2016).

artículo científico publicado en 2016

Dual self-regulated delivery of insulin and glucagon by a hybrid patch

artículo científico publicado en 2020

Effect of Insulin Glargine Up-titration vs Insulin Degludec/Liraglutide on Glycated Hemoglobin Levels in Patients With Uncontrolled Type 2 Diabetes: The DUAL V Randomized Clinical Trial

artículo científico

Effect of Naltrexone-Bupropion on Major Adverse Cardiovascular Events in Overweight and Obese Patients With Cardiovascular Risk Factors: A Randomized Clinical Trial

artículo científico

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes

artículo científico publicado en 2015

Effect of aleglitazar on cardiovascular outcomes after acute coronary syndrome in patients with type 2 diabetes mellitus: the AleCardio randomized clinical trial

artículo científico publicado en 2014

Effect of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors on colorectal cancer incidence and its precursors

artículo científico publicado en 2016

Effect of nateglinide on the incidence of diabetes and cardiovascular events

artículo científico publicado en 2010

Effect of relative weight group change on nuclear magnetic resonance spectroscopy derived lipoprotein particle size and concentrations among adolescents

scientific article published on 05 February 2014

Effect of valsartan on the incidence of diabetes and cardiovascular events

artículo científico publicado en 2010

Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes

artículo científico publicado en 2010

Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes

artículo científico publicado en 2017

Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes

artículo científico publicado en 2017

Effects of combination lipid therapy in type 2 diabetes mellitus

artículo científico publicado en 2010

Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes

artículo científico publicado en 2004

Effects of intensive blood-pressure control in type 2 diabetes mellitus

artículo científico publicado en 2010

Effects of sensor-augmented pump therapy on glycemic variability in well-controlled type 1 diabetes in the STAR 3 study

artículo científico publicado en 2012

Effects of therapy in type 1 and type 2 diabetes mellitus with a peptide derived from islet neogenesis associated protein (INGAP).

artículo científico publicado en 2009

Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes

artículo científico

Efficacy and Safety of Liraglutide Added to Capped Insulin Treatment in Subjects With Type 1 Diabetes: The ADJUNCT TWO Randomized Trial

artículo científico publicado en 2016

Efficacy and safety of a fixed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with its components given alone: results of a phase 3, open-label, randomised, 26-week, treat-to-target trial in insulin-naive patients with typ

artículo científico publicado en 2014

Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes (LEAD-4 Met+TZD).

artículo científico publicado en 2009

Efficacy of antihyperglycemic therapies and the influence of baseline hemoglobin A(1C): a meta-analysis of the liraglutide development program

artículo científico publicado en 2011

Efficacy, safety and tolerability of aleglitazar in patients with type 2 diabetes: pooled findings from three randomized phase III trials

artículo científico publicado en 2015

Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial

artículo científico publicado en 2002

Electronic medical record cancer incidence over six years comparing new users of glargine with new users of NPH insulin

artículo científico publicado en 2014

Endothelial dysfunction: associations with exposure to ambient fine particles in diabetic individuals

artículo científico publicado en 2008

Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial

artículo científico publicado en 2010

Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium-Glucose Cotransporter 2 Inhibition

artículo científico publicado en 2015

Evaluation of the dual peroxisome proliferator-activated receptor α/γ agonist aleglitazar to reduce cardiovascular events in patients with acute coronary syndrome and type 2 diabetes mellitus: rationale and design of the AleCardio trial.

artículo científico publicado en 2013

Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years

artículo científico publicado en 2008

Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study

artículo científico publicado en 2012

Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study

artículo científico publicado en 2008

Exploring salivary proteomes in edentulous patients with type 2 diabetes

artículo científico publicado en 2012

Fast-acting insulin aspart versus insulin aspart in the setting of insulin degludec-treated type 1 diabetes: Efficacy and safety from a randomized double-blind trial

scholarly article by John Buse et al published December 2018 in Diabetes, Obesity and Metabolism

Follow-up report on the diagnosis of diabetes mellitus

artículo científico publicado en 2003

Frontline: diabetes--supplementing education and quality improvement in family medicine residency training

artículo científico publicado en 2008

GLP-1 receptor agonists and basal insulin in type 2 diabetes

artículo científico publicado en 2014

Genetic Predictors of Cardiovascular Mortality During Intensive Glycemic Control in Type 2 Diabetes: Findings From the ACCORD Clinical Trial

artículo científico publicado en 2016

Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.

artículo científico publicado en 2017

Glitazones and heart failure: critical appraisal for the clinician

artículo científico publicado en 2003

Glucose Self-monitoring in Non-Insulin-Treated Patients With Type 2 Diabetes in Primary Care Settings: A Randomized Trial

artículo científico

Glucose measurement: confounding issues in setting targets for inpatient management

artículo científico publicado en 2007

Glucose-responsive insulin patch for the regulation of blood glucose in mice and minipigs

artículo científico publicado en 2020

Glycemic Targets in Diabetes Care: Emerging Clarity after Accord

artículo científico publicado en 2015

H2O2-Responsive Vesicles Integrated with Transcutaneous Patches for Glucose-Mediated Insulin Delivery

artículo científico publicado en 2017

HLA-A2-matched peripheral blood mononuclear cells from type 1 diabetic patients, but not nondiabetic donors, transfer insulitis to NOD-scid/γc(null)/HLA-A2 transgenic mice concurrent with the expansion of islet-specific CD8+ T cells ⬇️

artículo científico publicado en 2011

Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial

artículo científico publicado en 2016

Hormonal/metabolic regulation of the human GLUT4/muscle-fat facilitative glucose transporter gene in transgenic mice

artículo científico publicado en 1993

How do we define cure of diabetes?

artículo científico publicado en 2009

Hypertension Control in Adults With Diabetes Mellitus and Recurrent Cardiovascular Events: Global Results From the Trial Evaluating Cardiovascular Outcomes With Sitagliptin

artículo científico publicado en 2017

Hypoglycemia, Cardiovascular Outcomes, and Death: The LEADER Experience

Hypoxia and H2O2 Dual-Sensitive Vesicles for Enhanced Glucose-Responsive Insulin Delivery.

artículo científico publicado en 2017

IDegLira Improves Both Fasting and Postprandial Glucose Control as Demonstrated Using Continuous Glucose Monitoring and a Standardized Meal Test

artículo científico publicado en 2015

INHIBITION OF GLUCOSE-STIMULATED INSULIN RELEASE FROM βTC3 CELLS AND RODENT ISLETS BY AN ANALOG OF FK506

Identification of clinically relevant dysglycemia phenotypes based on continuous glucose monitoring data from youth with type 1 diabetes and elevated hemoglobin A1c

artículo científico publicado en 2019

Impact of adjunctive thiazolidinedione therapy on blood lipid levels and glycemic control in patients with type 2 diabetes

artículo científico publicado en 2004

Improved Time in Range and Glycemic Variability With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: A Pooled Analysis of 24-Week Continuous Glucose Monitoring Data From the inTandem Program

scientific article published on 04 March 2019

Increased Risk of Severe Hypoglycemic Events Before and After Cardiovascular Outcomes in TECOS Suggests an At-Risk Type 2 Diabetes Frail Patient Phenotype

artículo científico publicado en 2018

Incretin-Based Therapies and Diabetic Retinopathy: Real-World Evidence in Older U.S. Adults

artículo científico publicado en 2018

Incretin-based therapies for the treatment of type 2 diabetes: evaluation of the risks and benefits

artículo científico publicado en 2010

Insulin Dose and Cardiovascular Mortality in the ACCORD Trial

artículo científico publicado en 2015

Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority tria

artículo científico publicado en 2012

Insulin glargine (HOE901): first responsibilities: understanding the data and ensuring safety

artículo científico publicado en 2000

Insulin-Responsive Glucagon Delivery for Prevention of Hypoglycemia

artículo científico publicado en 2017

Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials

scientific article published on 17 December 2008

Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Card

artículo científico publicado en 2009

Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Card

artículo científico publicado en 2008

International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium–Glucose Cotransporter (SGLT) Inhibitors

artículo científico publicado en 2019

Is insulin the most effective injectable antihyperglycaemic therapy?

artículo científico publicado en 2014

LEADER 2: baseline calcitonin in 9340 people with type 2 diabetes enrolled in the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results (LEADER) trial: preliminary observations.

artículo científico publicado en 2015

LEADER 3--lipase and amylase activity in subjects with type 2 diabetes: baseline data from over 9000 subjects in the LEADER Trial

artículo científico publicado en 2014

LEADER 7: cardiovascular risk profiles of US and European participants in the LEADER diabetes trial differ

artículo científico publicado en 2016

Lack of association between thiazolidinediones and macular edema in type 2 diabetes: the ACCORD eye substudy

artículo científico publicado en 2010

Liraglutide Reduces Cardiovascular Events and Mortality in Type 2 Diabetes Mellitus Independently of Baseline Low-Density Lipoprotein Cholesterol Levels and Statin Use

artículo científico publicado en 2018

Liraglutide Treatment Is Associated with a Low Frequency and Magnitude of Antibody Formation with No Apparent Impact on Glycemic Response or Increased Frequency of Adverse Events: Results from the Liraglutide Effect and Action in Diabetes (LEAD) Tria

article

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

artículo científico publicado en 2016

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

scientific article published on 01 November 2016

Liraglutide and Glycaemic Outcomes in the LEADER Trial

Liraglutide and Renal Outcomes in Type 2 Diabetes

artículo científico publicado en 2017

Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6).

artículo científico publicado en 2009

Long-Term Effects of Intensive Glucose Lowering on Cardiovascular Outcomes ⬇️

artículo científico publicado el 3 de marzo de 2011

Long-term efficacy and safety of oral semaglutide and the effect of switching from sitagliptin to oral semaglutide in patients with type 2 diabetes: a 52-week, randomized, open-label extension of the PIONEER 7 trial

artículo científico publicado en 2020

Low-density lipoprotein cholesterol versus particle number in middle school children

artículo científico publicado en 2013

Lymphocyte abnormalities in the BB rat

artículo científico publicado en 1983

Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

scientific article published on 04 October 2018

Management of glycemia in type 2 diabetes.

artículo científico publicado en 1998

Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy. Update regarding the thiazolidinediones.

artículo científico publicado en 2008

Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes

artículo científico publicado en 2015

Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.

artículo científico publicado en 2006

Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

artículo científico publicado en 2012

Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes

artículo científico publicado en 2015

Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes

artículo científico publicado en 2006

Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: update regarding thiazolidinediones: a consensus statement from the American Diabetes Association and the European Association for th

artículo científico publicado en 2008

Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364–1379.

artículo científico publicado en 2013

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

artículo científico publicado en 2012

Maria Gordon Buse, MD: A Family Affair Through Six Decades of Diabetes Discovery

artículo científico publicado en 2016

Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes

artículo científico publicado en 2008

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

artículo científico publicado en 2009

Medications for type 2 diabetes: how will we be treating patients in 50 years?

artículo científico publicado en 2015

Metabolic effects of two years of exenatide treatment on diabetes, obesity, and hepatic biomarkers in patients with type 2 diabetes: an interim analysis of data from the open-label, uncontrolled extension of three double-blind, placebo-controlled tr

artículo científico publicado en 2007

Metabolic side effects of antipsychotics: focus on hyperglycemia and diabetes.

artículo científico publicado en 2002

Metabolomic characteristics of arsenic-associated diabetes in a prospective cohort in Chihuahua, Mexico

artículo científico publicado en 2015

Metformin Use May Moderate the Effect of DPP-4 Inhibitors on Cardiovascular Outcomes.

artículo científico publicado en 2017

Microneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin delivery

artículo científico publicado en 2015

Microneedles Integrated with Pancreatic Cells and Synthetic Glucose-Signal Amplifiers for Smart Insulin Delivery

artículo científico publicado en 2016

More realistic power estimation for new user, active comparator studies: an empirical example

artículo científico publicado en 2015

Muraglitazar, a dual (alpha/gamma) PPAR activator: a randomized, double-blind, placebo-controlled, 24-week monotherapy trial in adult patients with type 2 diabetes

artículo científico publicado en 2005

Myeloid-derived suppressor cells are increased in frequency but not maximally suppressive in peripheral blood of Type 1 Diabetes Mellitus patients

artículo científico publicado en 2014

Neoplasms Reported With Liraglutide or Placebo in People With Type 2 Diabetes: Results From the LEADER Randomized Trial

artículo científico publicado en 2018

No increased risk of cardiovascular events in older adults initiating dipeptidyl peptidase-4 inhibitors vs therapeutic alternatives.

artículo científico publicado en 2017

North Carolina internists' and endocrinologists' knowledge, opinions, and behaviors regarding periodontal disease and diabetes: need and opportunity for interprofessional education.

artículo científico publicado en 2011

Novel measures of inflammation and insulin resistance are related to obesity and fitness in a diverse sample of 11-14 year olds: The HEALTHY Study

artículo científico publicado en 2016

Once-daily delayed-release metformin lowers plasma glucose and enhances fasting and postprandial GLP-1 and PYY: results from two randomised trials

artículo científico publicado en 2016

One-year efficacy and safety of a fixed combination of insulin degludec and liraglutide in patients with type 2 diabetes: results of a 26-week extension to a 26-week main trial

artículo científico publicado en 2015

Outcomes of combined cardiovascular risk factor management strategies in type 2 diabetes: the ACCORD randomized trial

artículo científico publicado en 2014

Pancreatic Safety of Sitagliptin in the TECOS Study

artículo científico publicado en 2016

Panel discussion on achieving glycemic control.

artículo científico publicado en 2001

Peripheral blood mononuclear cell dihydropyrimidine dehydrogenase activity in volunteers with and without diabetes mellitus

artículo científico publicado en 1996

Personalized management of hyperglycemia in type 2 diabetes: reflections from a Diabetes Care Editors' Expert Forum

artículo científico publicado en 2013

Physician attitudes and practices and patient awareness of the cardiovascular complications of diabetes

artículo científico publicado en 2002

Pioglitazone and Rosiglitazone Have Different Effects on Serum Lipoprotein Particle Concentrations and Sizes in Patients With Type 2 Diabetes and Dyslipidemia

artículo científico publicado en 2007

Plasmid-encoded proinsulin preserves C-peptide while specifically reducing proinsulin-specific CD8⁺ T cells in type 1 diabetes

artículo científico publicado en 2013

Potential for use of 1,5-anhydroglucitol when initiating insulin therapy in people with type 2 diabetes and suboptimal control with oral antidiabetic drugs

article

Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: current knowledge and rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

artículo científico publicado en 2007

Prevention of cardiovascular outcomes in type 2 diabetes mellitus: trials on the horizon

artículo científico publicado en 2005

Prevention of cardiovascular outcomes in type 2 diabetes mellitus: trials on the horizon

Prevention or delay of type 2 diabetes

artículo científico publicado en 2004

Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus: A Scientific Statement From the American Heart Association and the American Diabetes Association

artículo científico publicado en 2006

Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association

artículo científico publicado en 2007

Primum Non Nocere: Refocusing Our Attention on Severe Hypoglycemia Prevention

artículo científico publicado en 2018

Quality of diabetes care in U.S. academic medical centers: low rates of medical regimen change

scientific article published on February 2005

Racial and ethnic differences in mean plasma glucose, hemoglobin A1c, and 1,5-anhydroglucitol in over 2000 patients with type 2 diabetes.

artículo científico publicado en 2009

Randomized Clinical Trial Comparing Basal Insulin Peglispro and Insulin Glargine in Patients With Type 2 Diabetes Previously Treated With Basal Insulin: IMAGINE 5.

artículo científico publicado en 2015

Rationale and design of the EXenatide Study of Cardiovascular Event Lowering (EXSCEL) trial.

artículo científico publicado en 2015

Rationale and design of the glycemia reduction approaches in diabetes: a comparative effectiveness study (GRADE).

artículo científico publicado en 2013

Real-world evidence on sodium-glucose cotransporter-2 inhibitor use and risk of Fournier's gangrene

artículo científico publicado en 2020

Recommendations for management of diabetes during Ramadan

artículo científico publicado en 2005

Recommendations for management of diabetes during Ramadan: update 2010.

artículo científico publicado en 2010

Red Blood Cells for Glucose-Responsive Insulin Delivery

artículo científico publicado en 2017

Response to Comment on Cefalu et al. Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors' Expert Forum. Diabetes Care 2016;39:1186-1201.

artículo científico publicado en 2017

Response to comment on Hempe et al. The hemoglobin glycation index identifies subpopulations with harms or benefits from intensive treatment in the ACCORD trial. Diabetes Care 2015;38:1067-1074.

artículo científico publicado en 2015

Retrospective analysis of risk factors in patients with treatment-emergent diabetes during clinical trials of antipsychotic medications.

artículo científico publicado en 2004

Reversibility of fenofibrate therapy-induced renal function impairment in ACCORD type 2 diabetic participants

artículo científico publicado en 2012

Risk Factors Associated With Severe Hypoglycemia in Older Adults With Type 1 Diabetes

artículo científico publicado en 2015

Salivary proteins associated with hyperglycemia in diabetes: a proteomic analysis

artículo científico publicado en 2013

Screening for diabetes and prediabetes with proposed A1C-based diagnostic criteria: comment on Olson et al.

artículo científico publicado en 2010

Sensor-augmented pump therapy for A1C reduction (STAR 3) study: results from the 6-month continuation phase

artículo científico publicado en 2011

Serum 1,5-anhydroglucitol (GlycoMark ): a short-term glycemic marker

artículo científico publicado en 2003

Should Postprandial Glucose Be Routinely Measured and Treated to a Particular Target? No! ⬇️

artículo científico publicado el 1 de mayo de 2003

Should postprandial glucose be routinely measured and treated to a particular target? Connecting the two sides of the debate

artículo científico publicado en 2003

Sitagliptin and risk of fractures in type 2 diabetes: Results from the TECOS trial.

artículo científico publicado en 2016

Small intestine hexose transport in experimental diabetes. Increased transporter mRNA and protein expression in enterocytes.

artículo científico publicado en 1994

Sodium-Glucose Cotransporter 2 Inhibitors and Diabetic Ketoacidosis: A Case Series From Three Academic Institutions

artículo científico publicado en 2017

Sodium-glucose co-transporter-2 inhibitor use and risk of lower-extremity amputation: Evolving questions, evolving answers

artículo científico publicado en 2019

Sotagliflozin in Combination With Optimized Insulin Therapy in Adults With Type 1 Diabetes: The North American inTandem1 Study

artículo científico publicado en 2018

Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Type 1 Diabetes

artículo científico publicado en 2015

Specific Class II Histocompatibility Gene Polymorphism in BB Rats

article

Strategies for multivessel revascularization in patients with diabetes

artículo científico publicado en 2012

Subcutaneous injection of hyaluronidase with recombinant human insulin compared with insulin lispro in type 1 diabetes

scientific article published on 19 June 2014

Switching to once-daily liraglutide from twice-daily exenatide further improves glycemic control in patients with type 2 diabetes using oral agents

artículo científico publicado en 2010

Synthetic beta cells for fusion-mediated dynamic insulin secretion

artículo científico publicado en 2017

Synthetic exendin-4 (exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes

artículo científico publicado en 2003

T-cell antigen receptor alpha chain polymorphisms in insulin-dependent diabetes

artículo científico publicado en 1988

The DURAbility of Basal versus Lispro mix 75/25 insulin Efficacy (DURABLE) trial: comparing the durability of lispro mix 75/25 and glargine ⬇️

artículo científico publicado en 2011

The GENNID Study. A resource for mapping the genes that cause NIDDM.

artículo científico publicado en 1996

The HEALTHY study: introduction

artículo científico publicado en 2009

The Primary Glucose-Lowering Effect of Metformin Resides in the Gut, Not the Circulation: Results From Short-term Pharmacokinetic and 12-Week Dose-Ranging Studies

artículo científico publicado en 2015

The Risk of Acute Pancreatitis After Initiation of Dipeptidyl Peptidase 4 Inhibitors: Testing a Hypothesis of Subgroup Differences in Older U.S. Adults

scientific article published on 04 April 2018

The War Is Not Yet Won.

artículo científico publicado en 2017

The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study

artículo científico publicado en 2010

The case for a role for postprandial glucose monitoring in diabetes management

scientific article published on 01 November 1998

The degree of retinopathy is equally predictive for renal and macrovascular outcomes in the ACCORD Trial

artículo científico publicado en 2014

The effects of oral anti-hyperglycaemic medications on serum lipid profiles in patients with type 2 diabetes.

artículo científico publicado en 2004

The hemoglobin glycation index identifies subpopulations with harms or benefits from intensive treatment in the ACCORD trial

artículo científico publicado en 2015

The insulin resistance syndrome and coronary artery disease

artículo científico publicado en 2003

The insulin resistance syndrome and coronary artery disease

scholarly article by David M. Kendall et al published June 2003 in Coronary Artery Disease

The metabolic syndrome

scientific article published on 01 December 2005

The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes

artículo científico publicado en 2005

The prevention or delay of type 2 diabetes

article

The role of obsessive-compulsive symptoms in the psychopathological profile of children with chronic tic disorder and attention-deficit hyperactivity disorder

artículo científico publicado en 2013

The safety of incretin-based therapies--review of the scientific evidence

artículo científico publicado en 2011

Thiazolidinediones in the treatment of type 2 diabetes: a clinician's perspective.

artículo científico publicado en 2000

Three approaches to glucose monitoring in non-insulin treated diabetes: a pragmatic randomized clinical trial protocol ⬇️

artículo científico publicado en 2017

Treatment of postprandial hyperglycemia in type 2 diabetes.

artículo científico publicado en 2001

Troglitazone use in insulin-treated type 2 diabetic patients. The Troglitazone Insulin Study Group

artículo científico publicado en 1998

Two genes required for diabetes in BB rats. Evidence from cyclical intercrosses and backcrosses

artículo científico publicado en 1984

Type 2 diabetes mellitus in 2010: individualizing treatment targets in diabetes care

artículo científico publicado en 2011

Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors' Expert Forum

artículo científico publicado en 2016

Urinary Catalytic Iron in Patients with Type 2 Diabetes without Microalbuminuria--a Substudy of the ACCORD Trial

artículo científico publicado en 2010

Use of Twice-Daily Exenatide in Basal Insulin–Treated Patients With Type 2 Diabetes

artículo científico publicado en 2010

Validation of distinct type 2 diabetes clusters and their association with diabetes complications in the DEVOTE, LEADER and SUSTAIN-6 cardiovascular outcomes trials

artículo científico publicado en 2020

We can change the natural history of type 2 diabetes

artículo científico publicado en 2014

Weight change with liraglutide and comparator therapies: an analysis of seven phase 3 trials from the liraglutide diabetes development programme.

artículo científico publicado en 2012

What We Think and What We Know

scientific article published on 01 October 2002

[Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes]

scientific article published on 01 May 2012

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda